Company
is dedicated to addressing challenging cancers unresponsive to current immunotherapies
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| March Biosciences | Series A Funding | 2024-10-23 |
Company
| Company | Round | Date | Lead |
|---|---|---|---|
| March Biosciences | Series A Funding | 2024-10-23 |